Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

42,193 stories, page 509 of 704

Advanced search

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Biotech listings back with a bang – Nordic player among record-breaking companies

BiostockOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Legend Biotech (NASDAQ: LEGN) reports $657M CARVYKTI sales

Stock TitanOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

BriaCell Taps FUJIFILM to Make Breast Cancer Cell Therapy

Stock TitanOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

A16z-Backed Heart Drug Biotech Braveheart Files for Nasdaq IPO

Bloomberg.comOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Jim Cramer crowns one surging sector the hottest in the market

thestreet.comOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Are you the new CEO of Swiss Biotech Association?

mva.orgOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Top 10 Hydroxy Propyl Methyl Cellulose Exporter from China at CPhI China 2026

EIN NewsOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Up to 90% of women reported better hair coverage by Month 6

Stock TitanOriginal source

🇺🇰Jul 15Researchstgeorges.nhs.ukTier 2 · Direct publisher

New digital wayfinding service helps patients and visitors find their way around our hospitals

St George's University HospitalsOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Johnson & Johnson shares fall despite better-than-expected results

medwatch.comOriginal source

🇺🇰Jul 15Researchstgeorges.nhs.ukTier 2 · Direct publisher

New gesh Carers Survey launched

St George's University HospitalsOriginal source

🌍Jul 15discoverynews.google.comTier 2 · Trade media

AstraZeneca pays up to $1.5bn to license Dizal Pharma’s lung cancer drug

Pharmaceutical TechnologyOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Sichuan Kelun-Biotech Biopharmaceutical and Harbour Biomed Receive Nmpa Approval of Ind Application for Skb575/Hbm7575 for the Treatment of Asthma

marketscreener.comOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Biogen shares slide as diranersen data raise dosing question

The Pharma LetterOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

FDA suspends licence of Salunkhe Vihar Road cafe over hygiene lapses

MSNOriginal source

🇺🇰Jul 15Regulatorygov.ukTier 1 · Regulatory source

Government and Joe Wicks support families to stay active

Families across the country are being encouraged to help children stay active over the summer holida...

UK Department of Health and Social CareOriginal source

🇺🇸Jul 15Industryjnj.comTier 1 · Company source

Johnson & Johnson reports Q2 2026 results, raises 2026 outlook

2025 Second-Quarter reported sales growth of 5.8% to $23.7 Billion with operational growth of 4.6%*...

Johnson & Johnson NewsOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Sinovac Biotech (NASDAQ: SVA) extends $55 per share dividend deadline

Stock TitanOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Harbour BioMed and Kelun-Biotech Announce NMPA Approval of IND Application for HBM7575/SKB575 for the Treatment of Asthma

PR NewswireOriginal source

🇺🇰Jul 15Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Combination antithrombotic therapy in atrial fibrillation after coronary interventions: shorter duration, more safety?

PubMed Lancet RSSOriginal source

🇺🇰Jul 15Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial

PubMed Lancet RSSOriginal source

🇺🇰Jul 15Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Bundibugyo ebolavirus from the 2026 Ebola outbreak in Uganda and DR Congo: a new variant

PubMed Lancet RSSOriginal source

🇺🇰Jul 15Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Embracing neurodiversity in medicine: insights from the history of psychiatry

PubMed Lancet RSSOriginal source

🇺🇰Jul 15Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Deep brain stimulation for the treatment of patients with dystonia: advances towards network-based personalised care

PubMed Lancet Neurology RSSOriginal source

🇺🇰Jul 15Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

The role of the gut microbiome in mediating neuroinflammation in immune-based neurological disorders

PubMed Lancet Neurology RSSOriginal source

🇺🇰Jul 15Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Survival estimates and their predictors in genetic frontotemporal dementia: an international, retrospective, cohort study

PubMed Lancet Neurology RSSOriginal source

🇺🇰Jul 15Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trial

PubMed Lancet Neurology RSSOriginal source

🇺🇸Jul 15Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis. Reply

PubMed NEJM RSSOriginal source

🇺🇸Jul 15Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Adjuvant Chemotherapy ± Chemoradiotherapy for Adenocarcinoma of the Pancreatic Head: Results of the Radiotherapy Random Assignment of NRG Oncology/RTOG 0848

PubMed Journal of Clinical Oncology RSSOriginal source

🇺🇸Jul 15Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Smoking in Patients With Cancer: Guidance for Delivering Effective Tobacco Treatment in Cancer Care

PubMed Journal of Clinical Oncology RSSOriginal source

🇺🇸Jul 15Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Erratum for the Research Article "Phase separation-based HTS identifies cobimetinib as a YAP-TEAD inhibitor that suppresses hyperactivated YAP-induced cancer progression"

PubMed Science Translational Medicine RSSOriginal source

🇺🇸Jul 15Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

CD4 + T cells reactive to Epstein-Barr virus late lytic antigens are enriched in individuals with multiple sclerosis

PubMed Science Translational Medicine RSSOriginal source

🇺🇸Jul 15Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

A small molecule reduces both parkinsonism and l-dopa-induced dyskinesia in animal models of Parkinson's disease

PubMed Science Translational Medicine RSSOriginal source

🇺🇸Jul 15Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Long-term safety and efficacy of intracortical microstimulation in humans

PubMed Science Translational Medicine RSSOriginal source

🇺🇸Jul 15Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

PTEN acts as a master mediator of nonhealing venous leg ulcers by suppressing immune response, angiogenesis, and lymphangiogenesis

PubMed Science Translational Medicine RSSOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Kelun-Biotech and Harbour BioMed Announce NMPA Approval of IND Application for SKB575/HBM7575 for the Treatment of Asthma

PR NewswireOriginal source

🇺🇸Jul 15Researchmdanderson.orgTier 2 · Direct publisher

New breakthroughs in pancreatic cancer treatment and research

MD Anderson Cancer CenterOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

A Complete Guide to Pharmaceutical Ingredients: Serum Pharma’s APIs, Plant Extracts & Nutraceutical Solutions

EIN NewsOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Is Definium Therapeutics, Inc. (DFTX) Stock a Biotech Opportunity After Positive DT120 Depression Trial Data?

Yahoo FinanceOriginal source

🇫🇷Jul 15Regulatoryleem.orgTier 1 · Regulatory source

Le Leem finalise sa gouvernance et se mobilise pour les grandes échéances politiques de santé à venir

LEEM FranceOriginal source

🇺🇰Jul 15Regulatorygov.ukTier 1 · Regulatory source

Pathogen genomics at Porton Down

The Pathogen Genomics Department at Porton Down provides a sequencing service for SARS-CoV-2 for cus...

UK Health Security AgencyOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Zydus Lifesciences seals $150 million Sterling Biotech deal

The Pharma LetterOriginal source

🇺🇰Jul 15Regulatorygov.ukTier 1 · Regulatory source

Framework agreement between DHSC and the UK Health Security Agency: 2026 to 2029

Describes the working relationship between the Department of Health and Social Care and the UK Healt...

UK Health Security AgencyOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

HHS and FDA Respond to DEA’s Action on Kratom-Related Products

The Presidential Prayer TeamOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Harel Insurance Investments & Financial Services Ltd. Increases Position in Teva Pharmaceutical Industries Ltd. $TEVA

MarketBeatOriginal source

🌍Jul 15discoverynews.google.comTier 2 · Trade media

A new biotech startup tries to tackle obesity, but not in the way you might expect

STATOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Biotech firm that went viral for plans to create 'nonsentient humanoids' for organ harvesting now says it was never true

WIONOriginal source

🇺🇰Jul 15Researched.ac.ukTier 2 · Direct publisher

Scottish Traveller study uncovers unique genetics

University of EdinburghOriginal source

🇺🇰Jul 15Regulatorygov.ukTier 1 · Regulatory source

UKHSA FluSurvey surveillance system

Information on the FluSurvey surveillance system data.

UK Health Security AgencyOriginal source

🇺🇰Jul 15Regulatorygov.ukTier 1 · Regulatory source

UK Clinical Research Delivery key performance indicators: data to June 2026

Report bringing together data on the delivery of globally competitive clinical research through the...

UK Department of Health and Social CareOriginal source

🇺🇰Jul 15Regulatorygov.ukTier 1 · Regulatory source

'It looks done': Common BBQ blunders and how to avoid them

Simple advice from the FSA will help you avoid the grilling gaffes and common mistakes which could m...

UK Health Security AgencyOriginal source

🇺🇰Jul 15Regulatorygov.ukTier 1 · Regulatory source

Bloodborne virus (BBV) related infection control breaches: management toolkit

This guidance supports risk assessment, investigation and management of infection control breaches,...

UK Health Security AgencyOriginal source

🇺🇰Jul 15Regulatorygov.ukTier 1 · Regulatory source

Tuberculosis in England, 2025 report

Incidence, treatment and prevention of tuberculosis (TB) in England using data up until the end of 2...

UK Health Security AgencyOriginal source

🌍Jul 15discoverynews.google.comTier 2 · Trade media

Attovia files for IPO to take on Sanofi and Regeneron’s Dupixent

Fierce BiotechOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Diversify Wealth Management LLC Buys 54,488 Shares of Teva Pharmaceutical Industries Ltd. $TEVA

MarketBeatOriginal source

🌍Jul 15discoverynews.google.comTier 2 · Trade media

I&I startup Attovia files to go public as biotech listings momentum builds

Endpoints NewsOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Biotech Growth Trust Gains 19.2% In June, Outperforms Benchmark

DirectorsTalk InterviewsOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Hemab’s Sutacimig Cuts Bleeds 84% in Phase 2 Glanzmann Thrombasthenia Study

The Clinical Trial VanguardOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

ORIC Initiates Himalayas-1 Phase 3 Trial of Rinzimetostat for mCRPC

The Clinical Trial VanguardOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

RTW Biotech Opportunities reports 9.7% June NAV increase

Investing.comOriginal source